Published with this product (3)
2017Molecular Psychiatry
Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential
A J Sandweiss, M I McIntosh, A Moutal, R Davidson-Knapp, J Hu, A K Giri, T Yamamoto, V J Hruby, R Khanna, T M Largent-Milnes and T W Vanderah
doi:10.1038/mp.2017.1022016Journal of Neurophysiology
Shigekazu Sugino, Mohamed Farrag, Victor Ruiz-Velasco
doi:10.1152/jn.00980.20152008The Journal of Comparative Neurology
Anatomical and functional characterization of neuropil in the gracile fasciculus
Matt Ramer
doi:10.1002/cne.21785
Description
The tachykinins belong to an evolutionary conserved family of peptide neurotransmitters that share the c-terminal sequence Phe-X-Gly-Leu-Met-NH2 and have an established role in neurotransmission. The mammalian tachykinins include substance P, neurokinin A (NKA) and neurokinin B (NKB) which exert their effects by binding to specific receptors. Tachykinin peptides are important in the mediation of many physiological and pathological processes including inflammation, pain, migraine headache and allergy induced asthma.
Related products
- beta-Lipotropin
- CCK-8 (Cholecystokinin Octapeptide)
- CGRP
- FMRFamide
- Leu-Enkephalin
- Met-Enkephalin
- Neurokinin-1 (NK 1) Receptor
- Neurokinin-3 (NK 3) Receptor
- Neuropeptide FF1 Receptor
- Neuropeptide FF2 Receptor
- Neuropeptide Q3/NPQ3
- Neurotensin
For research use only. Not for diagnostic or clinical use.
